EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/8725471
Conclusion of this study
Due to its multiple pharmacological actions, EGb 761 provides an interesting response to the prevention of mountain sickness for moderate altitude (5400 m) with gradual exposure. It also decreased vasomotor disorders of the extremities, as demonstrated by plethysmography (p < 10(-8)) and a specific questionnaire (p < 10(-9)).
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study